PATENT CLAIM ANALYSIS

Application Number: 16051892
Application Type: Utility
Filing Date: 2018-08
Publication Date: 2019-01
Patent Classification: ["546", "133000"]

Abstract:
The invention relates to a method of preparing inhibitors of glucosylceramide synthase (GCS) useful for the treatment metabolic diseases, such as lysosomal storage diseases, either alone or in combination with enzyme replacement therapy, and for the treatment of cancer.

Claim (Index 32):
A compound of Formula XI

Metadata:
- Claim Count in Document: 8.0
- Percentile: 96.0
- Lexical Diversity: 1.21622
- Patent Class: 546.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15593440', '14776443', '15313800', '14618986', '13619788']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.715371274425535
- 35 USC 102 Novelty (BERT): 0.5346891842364558
- Combined Prediction Score: 0.6973030654066271
- Mean Citation Score: 266.64582200000007
- Max Citation Score: 325.35367
- Similarity Product: 170.45628880464318

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test